1CM
ITCI
1492 Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52,537
| Closed | -$4.39M | – | 129 |
|
|
2024
Q4 | $4.39M | Sell |
52,537
-322
| -0.6% | -$26.9K | 2.09% | 17 |
|
|
2024
Q3 | $3.87M | Sell |
52,859
-261
| -0.5% | -$19.1K | 1.93% | 19 |
|
|
2024
Q2 | $3.64M | Buy |
53,120
+17,857
| +51% | +$1.22M | 2.06% | 18 |
|
|
2024
Q1 | $2.44M | Sell |
35,263
-30
| -0.1% | -$2.08K | 1.36% | 31 |
|
|
2023
Q4 | $2.53M | Buy |
35,293
+361
| +1% | +$25.9K | 1.44% | 25 |
|
|
2023
Q3 | $1.82M | Hold |
34,932
| – | – | 1.17% | 29 |
|
|
2023
Q2 | $2.21M | Sell |
34,932
-17
| -0% | -$1.08K | 1.29% | 27 |
|
|
2023
Q1 | $1.89M | Sell |
34,949
-12
| -0% | -$650 | 1.17% | 29 |
|
|
2022
Q4 | $1.85M | Hold |
34,961
| – | – | 1.19% | 27 |
|
|
2022
Q3 | $1.63M | Buy |
34,961
+10,891
| +45% | +$507K | 1.17% | 28 |
|
|
2022
Q2 | $1.37M | Buy |
+24,070
| New | +$1.37M | 0.9% | 38 |
|